Odette Cancer Program

Education:

• MD, 2009, McGill University, Canada
• FRCPC, 2012, internal medicine, University of Toronto, Canada
• FRCPC, 2014, hematology, U of T
• Fellowship, 2016, lymphoma and myelodysplastic syndromes, Sunnybrook Health Sciences Centre
• Fellowship, 2016, Veterans Health Administration Quality Scholars, U.S.
• Master of Public Health, 2021, T.H. Chan School of Public Health, Harvard University, U.S.

Appointments and Affiliations:

• Affiliate scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute
• Clinical hematologist, division of medical oncology/hematology, department of medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre
• Assistant professor, division of medical oncology/hematology, department of medicine, faculty of medicine, University of Toronto
• Adjunct scientist, Institute for Clinical Evaluative Sciences

Research Foci:

• Myelodysplastic syndromes and lymphoma
• Health services research
• Impact of patient-related factors on treatment outcomes

Research Summary:

Dr. Mozessohn’s research focuses on health services and outcomes-based research in hematologic cancers, including the impact of patient-related factors on treatment outcomes. He is supported by funding from the Ontario Institute for Cancer Research.

Selected Publications:

See current publications list at PubMed.

Related News and Stories:

• Research into cancer technologies and services recognized with funding: Six Sunnybrook Research Institute scientists working in prevention, screening and care receive support from provincial network (June 4, 2019)